Identification of novel peptide inhibitors for the KRas-G12C variant to prevent oncogenic signaling

References

• Agrawal, P., Bhagat, D., Mahalwal, M., Sharma, N., & Raghava, G. P. (2021). Anticp 2.0: An updated model for predicting anticancer peptides. Briefings in Bioinformatics, 22(3), bbaa153. https://doi.org/10.1093/bib/bbaa153
   PubMed Web of Science ®Google Scholar
• Ahmad, S. U., Ali, Y., Jan, Z., Rasheed, S., Nazir, N. U. A., Khan, A., Rukh Abbas, S., Wadood, A., & Rehman, A. U. (2022). Computational screening and analysis of deleterious nssnps in human p14arf (cdkn2a gene) protein using molecular dynamic simulation approach. Journal of Biomolecular Structure and Dynamics, 40, 1–12. https://doi.org/10.1080/07391102.2022.2059570
   PubMedGoogle Scholar
• Ahmad, S. U., Hafeez Kiani, B., Abrar, M., Jan, Z., Zafar, I., Ali, Y., Alanazi, A. M., Malik, A., Rather, M. A., Ahmad, A., & Khan, A. A. (2022). A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of sars-cov-2 and its variant omicron among different countries. Journal of Infection and Public Health, 15(8), 878–891. https://doi.org/10.1016/j.jiph.2022.07.002
   PubMed Web of Science ®Google Scholar
• Ali, Y., Yasin, M., Aziz, A., Khan, A. W., Ur Rahman, S., & Haq, N. U. (2022). In-silico analysis of 2-cysteine peroxiredoxin genes in arabidopsis thaliana with possible role in carbon dioxide fixation through carbonic anhydrase regulation. Pakistan Journal of Biochemistry and Biotechnology, 3(1), 175–189. https://doi.org/10.52700/pjbb.v3i1.126
   Google Scholar
• Amadei, A., Linssen, A. B., & Berendsen, H. J. (1993). Essential dynamics of proteins. Proteins, 17(4), 412–425. https://doi.org/10.1002/prot.340170408
   PubMed Web of Science ®Google Scholar
• Bibi, S., & Sakata, K. (2017). An integrated computational approach for plant-based protein tyrosine phosphatase non-receptor type 1 inhibitors. Current Computer-Aided Drug Design, 13(4), 319–335.
   PubMed Web of Science ®Google Scholar
• Cabri, W., Cantelmi, P., Corbisiero, D., Fantoni, T., Ferrazzano, L., Martelli, G., Mattellone, A., & Tolomelli, A. (2021). Therapeutic peptides targeting ppi in clinical development: Overview, mechanism of action and perspectives. Frontiers in Molecular Biosciences, 8, 697586. https://doi.org/10.3389/fmolb.2021.697586
   PubMed Web of Science ®Google Scholar
• Chen, G-f., Xu, T-h., Yan, Y., Zhou, Y-r., Jiang, Y., Melcher, K., & Xu, H. E. (2017). Amyloid beta: Structure, biology and structure-based therapeutic development. Acta Pharmacologica Sinica, 38(9), 1205–1235. https://doi.org/10.1038/aps.2017.28
   PubMed Web of Science ®Google Scholar
• Cheng, H., & Planken, S. (2018). Precedence and promise of covalent inhibitors of egfr and kras for patients with non-small-cell lung cancer. ACS Medicinal Chemistry Letters, 9(9), 861–863. https://doi.org/10.1021/acsmedchemlett.8b00311
   PubMed Web of Science ®Google Scholar
• Cox, A. D., & Der, C. J. (2010). Ras history: The saga continues. Small GTPases, 1(1), 2–27. https://doi.org/10.4161/sgtp.1.1.12178
   PubMedGoogle Scholar
• Emmanuel, I. A., Olotu, F. A., Agoni, C., & Soliman, M. E. (2019). Deciphering the ‘elixir of life’: Dynamic perspectives into the allosteric modulation of mitochondrial atp synthase by j147, a novel drug in the treatment of alzheimer’s disease. Chemistry & Biodiversity, 16(6), e1900085.
   PubMed Web of Science ®Google Scholar
• Genheden, S., & Ryde, U. (2015). The mm/pbsa and mm/gbsa methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Ghufran, M., Rehman, A. U., Shah, M., Ayaz, M., Ng, H. L., & Wadood, A. (2020). In-silico design of peptide inhibitors of k-ras target in cancer disease. Journal of Biomolecular Structure & Dynamics, 38(18), 5488–5499. https://doi.org/10.1080/07391102.2019.1704880
   PubMed Web of Science ®Google Scholar
• Gotz, A. W., Williamson, M. J., Xu, D., Poole, D., Le Grand, S., & Walker, R. C. (2012). Routine microsecond molecular dynamics simulations with amber on gpus. 1. Generalized born. Journal of Chemical Theory and Computation, 8(5), 1542–1555. https://doi.org/10.1021/ct200909j
   PubMed Web of Science ®Google Scholar
• Gupta, S., Coronado, G. D., Argenbright, K., Brenner, A. T., Castañeda, S. F., Dominitz, J. A., Green, B., Issaka, R. B., Levin, T. R., Reuland, D. S., Richardson, L. C., Robertson, D. J., Singal, A. G., & Pignone, M. (2020). Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a centers for disease control and prevention–sponsored summit. CA: a Cancer Journal for Clinicians, 70(4), 283–298. https://doi.org/10.3322/caac.21615
   PubMed Web of Science ®Google Scholar
• Hancock, R. E., & Sahl, H.-G. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnology, 24(12), 1551–1557. https://doi.org/10.1038/nbt1267
   PubMed Web of Science ®Google Scholar
• Hassanpour, S. H., & Dehghani, M. (2017). Review of cancer from perspective of molecular. Journal of Cancer Research and Practice, 4(4), 127–129. https://doi.org/10.1016/j.jcrpr.2017.07.001
   Google Scholar
• Herdeis, L., Gerlach, D., McConnell, D. B., & Kessler, D. (2021). Stopping the beating heart of cancer: Kras reviewed. Current Opinion in Structural Biology, 71, 136–147. https://doi.org/10.1016/j.sbi.2021.06.013
   PubMed Web of Science ®Google Scholar
• Hillig, R. C., Sautier, B., Schroeder, J., Moosmayer, D., Hilpmann, A., Stegmann, C. M., Werbeck, N. D., Briem, H., Boemer, U., Weiske, J., Badock, V., Mastouri, J., Petersen, K., Siemeister, G., Kahmann, J. D., Wegener, D., Böhnke, N., Eis, K., Graham, K., … Bader, B. (2019). Discovery of potent SOS1 inhibitors that block ras activation via disruption of the RAS–SOS1 interaction. Proceedings of the National Academy of Sciences of the United States of America, 116(7), 2551–2560. https://doi.org/10.1073/pnas.1812963116
   PubMed Web of Science ®Google Scholar
• Hobbs, G. A., Wittinghofer, A., & Der, C. J. (2016). Selective targeting of the kras g12c mutant: Kicking kras when it’s down. Cancer Cell, 29(3), 251–253. https://doi.org/10.1016/j.ccell.2016.02.015
   PubMed Web of Science ®Google Scholar
• Holderfield, M. (2018). Efforts to develop kras inhibitors. Cold Spring Harbor Perspectives in Medicine, 8(7), a031864. https://doi.org/10.1101/cshperspect.a031864
   PubMed Web of Science ®Google Scholar
• Hou, T., Wang, J., Li, Y., & Wang, W. (2011). Assessing the performance of the mm/pbsa and mm/gbsa methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling, 51(1), 69–82. https://doi.org/10.1021/ci100275a
   PubMed Web of Science ®Google Scholar
• Ijaz, A., Shah, K., Aziz, A., Rehman, F. U., Ali, Y., Tareen, A. M., Khan, K., Ayub, M., & Wali, A. (2021). Novel frameshift mutations in xpc gene underlie xeroderma pigmentosum in pakistani families. Indian Journal of Dermatology, 66(2), 220–222. https://doi.org/10.4103/ijd.IJD_63_20
   PubMed Web of Science ®Google Scholar
• Jan, Z., Ahmad, S. U., Amara Qadus, Y. A., Sajjad, W., Rais, F., Tanveer, S., Khan, M. S., & Haq, I. (2021). 19. Insilico structural and functional assessment of hypothetical protein l345_13461 from ophiophagus hannah. Pure and Applied Biology (PAB), 10(4), 1109–1118.
   Google Scholar
• Junaid, M., Shah, M., Khan, A., Li, C.-D., Khan, M. T., Kaushik, A. C., Ali, A., Mehmood, A., Nangraj, A. S., Choi, S., & Wei, D.-Q. (2019). Structural-dynamic insights into the h. Pylori cytotoxin-associated gene a (caga) and its abrogation to interact with the tumor suppressor protein aspp2 using decoy peptides. Journal of Biomolecular Structure and Dynamics, 37(15), 4035–4050. https://doi.org/10.1080/07391102.2018.1537895
   PubMed Web of Science ®Google Scholar
• Khan, M. S., Mehmood, B., Yousafi, Q., Bibi, S., Fazal, S., Saleem, S., Sajid, M. W., Ihsan, A., Azhar, M., & Kamal, M. A. (2021). Molecular docking studies reveal rhein from rhubarb (rheum rhabarbarum) as a putative inhibitor of atp-binding cassette super-family g member 2. Medicinal Chemistry (Shariqah (United Arab Emirates)), 17(3), 273–288. https://doi.org/10.2174/1573406416666191219143232
   PubMed Web of Science ®Google Scholar
• Khattak, S., Rauf, M. A., Zaman, Q., Ali, Y., Fatima, S., Muhammad, P., Li, T., Khan, H. A., Khan, A. A., Ngowi, E. E., Wu, D.-D., & Ji, X.-Y. (2021). Genome-wide analysis of codon usage patterns of sars-cov-2 virus reveals global heterogeneity of covid-19. Biomolecules, 11(6), 912. https://doi.org/10.3390/biom11060912
   PubMed Web of Science ®Google Scholar
• Lamiable, A., Thévenet, P., Rey, J., Vavrusa, M., Derreumaux, P., & Tufféry, P. (2016). Pep-fold3: Faster de novo structure prediction for linear peptides in solution and in complex. Nucleic Acids Research, 44(W1), W449–W454. https://doi.org/10.1093/nar/gkw329
   PubMed Web of Science ®Google Scholar
• Lefèvre, F., Rémy, M.-H., & Masson, J.-M. (1997). Alanine-stretch scanning mutagenesis: A simple and efficient method to probe protein structure and function. Nucleic Acids Research, 25(2), 447–448.
   PubMed Web of Science ®Google Scholar
• Li, G., Xia, X., Long, Y., Li, J., Wu, J., & Zhu, Y. (2014). Research progresses and applications of antimicrobial peptides. Chinese Journal of Animal Nutrition, 26(1), 17–25.
   Google Scholar
• Liu, J., Kang, R., & Tang, D. (2021). The KRAS-G12C inhibitor: Activity and resistance. Nature Publishing Group, 29, 1–4.
   Google Scholar
• Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010). Stability of protein pharmaceuticals: An update. Pharmaceutical Research, 27(4), 544–575. https://doi.org/10.1007/s11095-009-0045-6
   PubMed Web of Science ®Google Scholar
• Marqus, S., Pirogova, E., & Piva, T. J. (2017). Evaluation of the use of therapeutic peptides for cancer treatment. Journal of Biomedical Science, 24(1), 1–15. https://doi.org/10.1186/s12929-017-0328-x
   PubMedGoogle Scholar
• Mathur, D., Prakash, S., Anand, P., Kaur, H., Agrawal, P., Mehta, A., Kumar, R., Singh, S., & Raghava, G. P. (2016). Peplife: A repository of the half-life of peptides. Scientific Reports, 6(1), 36617–36617. https://doi.org/10.1038/srep36617
   PubMedGoogle Scholar
• Meacham, C. E., & Morrison, S. J. (2013). Tumour heterogeneity and cancer cell plasticity. Nature, 501(7467), 328–337. https://doi.org/10.1038/nature12624
   PubMed Web of Science ®Google Scholar
• Merz, V., Gaule, M., Zecchetto, C., Cavaliere, A., Casalino, S., Pesoni, C., Contarelli, S., Sabbadini, F., Bertolini, M., Mangiameli, D., Milella, M., Fedele, V., & Melisi, D. (2021). Targeting kras: The elephant in the room of epithelial cancers. Frontiers in Oncology, 11, 638360. https://doi.org/10.3389/fonc.2021.638360
   PubMed Web of Science ®Google Scholar
• Mocanu, C. S., Niculaua, M., Zbancioc, G., Mangalagiu, V., & Drochioiu, G. (2022). Novel design of neuropeptide-based drugs with β-sheet breaking potential in amyloid-beta cascade: Molecular and structural deciphers. International Journal of Molecular Sciences, 23(5), 2857. https://doi.org/10.3390/ijms23052857
   PubMed Web of Science ®Google Scholar
• Ni, D., Song, K., Zhang, J., & Lu, S. (2017). Molecular dynamics simulations and dynamic network analysis reveal the allosteric unbinding of monobody to h-ras triggered by r135k mutation. International Journal of Molecular Sciences, 18(11), 2249. https://doi.org/10.3390/ijms18112249
   PubMed Web of Science ®Google Scholar
• Ostrem, J. M., & Shokat, K. M. (2016). Direct small-molecule inhibitors of kras: From structural insights to mechanism-based design. Nature Reviews. Drug Discovery, 15(11), 771–785. https://doi.org/10.1038/nrd.2016.139
   PubMed Web of Science ®Google Scholar
• Qiao, X., Wang, Y., & Yu, H. (2019). Progress in the mechanisms of anticancer peptides. Sheng wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology, 35(8), 1391–1400.
   PubMedGoogle Scholar
• Renaud, S., Seitlinger, J., & Massard, G. (2017). Micrornas: A new tool in the complex biology of kras mutated non-small cell lung cancer? Journal of Thoracic Disease, 9(4), 957–960. https://doi.org/10.21037/jtd.2017.03.56
   PubMed Web of Science ®Google Scholar
• Rose, P. W., Prlić, A., Altunkaya, A., Bi, C., Bradley, A. R., Christie, C. H., Costanzo, L. D., Duarte, J. M., Dutta, S., & Feng, Z. (2016). The RCSB protein data bank: Integrative view of protein, gene and 3D structural information. Nucleic Acids Research, 45, gkw1000.
   Web of Science ®Google Scholar
• Ryan, M. B., & Corcoran, R. B. (2018). Therapeutic strategies to target ras-mutant cancers. Nature Reviews. Clinical Oncology, 15(11), 709–720. https://doi.org/10.1038/s41571-018-0105-0
   PubMed Web of Science ®Google Scholar
• Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341. https://doi.org/10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Salomon-Ferrer, R., Case, D. A., & Walker, R. C. (2013). An overview of the amber biomolecular simulation package. Wiley Interdisciplinary Reviews: Computational Molecular Science, 3(2), 198–210.
   Web of Science ®Google Scholar
• Schaduangrat, N., Nantasenamat, C., Prachayasittikul, V., & Shoombuatong, W. (2019). Acpred: A computational tool for the prediction and analysis of anticancer peptides. Molecules, 24(10), 1973. https://doi.org/10.3390/molecules24101973
   PubMed Web of Science ®Google Scholar
• Shah, A. A., Amjad, M., Hassan, J.-U., Ullah, A., Mahmood, A., Deng, H., Ali, Y., Gul, F., & Xia, K. (2022). Molecular insights into the role of pathogenic nssnps in grin2b gene provoking neurodevelopmental disorders. Genes, 13(8), 1332. https://doi.org/10.3390/genes13081332
   PubMed Web of Science ®Google Scholar
• Stumpf, M. P., Thorne, T., De Silva, E., Stewart, R., An, H. J., Lappe, M., & Wiuf, C. (2008). Estimating the size of the human interactome. Proceedings of the National Academy of Sciences 105(19): 6959–6964.
   Google Scholar
• Swaminathan, S., Harte, W., Jr,., & Beveridge, D. L. (1991). Investigation of domain structure in proteins via molecular dynamics simulation: Application to hiv-1 protease dimer. Journal of the American Chemical Society, 113(7), 2717–2721. https://doi.org/10.1021/ja00007a054
   Web of Science ®Google Scholar
• Thundimadathil, J. (2012). Cancer treatment using peptides: Current therapies and future prospects. Journal of Amino Acids, 2012, 967347. https://doi.org/10.1155/2012/967347 PMID: 23316341.
   PubMedGoogle Scholar
• Tsuchida, N., Ryder, T., & Ohtsubo, E. (1982). Nucleotide sequence of the oncogene encoding the p21 transforming protein of Kirsten murine sarcoma virus. Science (New York, N.Y.), 217(4563), 937–939.
   PubMed Web of Science ®Google Scholar
• Tyagi, A., Kapoor, P., Kumar, R., Chaudhary, K., Gautam, A., & Raghava, G. (2013). In silico models for designing and discovering novel anticancer peptides. Scientific Reports, 3(1), 1–8. https://doi.org/10.1038/srep02984
   Google Scholar
• Usmani, S. S., Bedi, G., Samuel, J. S., Singh, S., Kalra, S., Kumar, P., Ahuja, A. A., Sharma, M., Gautam, A., & Raghava, G. P. (2017). Thpdb: Database of fda-approved peptide and protein therapeutics. PloS One, 12(7), e0181748.
   PubMed Web of Science ®Google Scholar
• Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010). Synthetic therapeutic peptides: Science and market. Drug Discovery Today, 15(1–2), 40–56.
   PubMed Web of Science ®Google Scholar
• Wadood, A., Riaz, M., Jamal, S. B., Shah, M., & Lodhi, M. A. (2013). Molecular docking study of p4-benzoxaborolesubstituted ligands as inhibitors of hcv ns3/4a protease. Bioinformation, 9(6), 309–314.
   PubMedGoogle Scholar
• Wadood, A., Shareef, A., Ur Rehman, A., Muhammad, S., Khurshid, B., Khan, R. S., Shams, S., & Afridi, S. G. (2022). In silico drug designing for ala438 deleted ribosomal protein s1 (rpsa) on the basis of the active compound zrl15. ACS Omega, 7(1), 397–408.
   PubMed Web of Science ®Google Scholar
• Wang, J.-B., Huang, X., & Li, F.-R. (2019). Impaired dendritic cell functions in lung cancer: A review of recent advances and future perspectives. Cancer Communications, 39(1), 43–11. https://doi.org/10.1186/s40880-019-0387-3
   Google Scholar
• Winter, J. J. G., Anderson, M., Blades, K., Brassington, C., Breeze, A. L., Chresta, C., Embrey, K., Fairley, G., Faulder, P., Finlay, M. R. V., Kettle, J. G., Nowak, T., Overman, R., Patel, S. J., Perkins, P., Spadola, L., Tart, J., Tucker, J. A., & Wrigley, G. (2015). Small molecule binding sites on the ras: Sos complex can be exploited for inhibition of ras activation. Journal of Medicinal Chemistry, 58(5), 2265–2274.
   PubMed Web of Science ®Google Scholar
• Xu, L-l., Li, C-c., An, L-y., Dai, Z., Chen, X-y., You, Q-d., Hu, C., & Di, B. (2020). Selective apoptosis-inducing activity of synthetic hydrocarbon-stapled SOS1 helix with d-amino acids in h358 cancer cells expressing krasg12c. European Journal of Medicinal Chemistry, 185(111844), 111844.
   PubMedGoogle Scholar
• Yue, P., & Moult, J. (2006). Identification and analysis of deleterious human snps. Journal of Molecular Biology, 356(5), 1263–1274.
   PubMed Web of Science ®Google Scholar